Macro-AST: misleading finding in an adolescent with MCAD-deficiency
<p>Abstract</p> <p>Background</p> <p>MCAD-deficiency is the most common inborn error of fatty acid oxidation now included in many newborn screening programms using MS/MS. During prolonged catabolic episodes, patients may suffer from metabolic decompensation with dysfunc...
Main Authors: | Das Anibh M, Drache Sabine, Janzen Nils, Franke Andreas |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-08-01
|
Series: | BMC Gastroenterology |
Subjects: | |
Online Access: | http://www.biomedcentral.com/1471-230X/12/119 |
Similar Items
-
Detection of Macro-Aspartate Aminotransferase (AST) in an Asymptomatic Patient with Persistent Elevation of AST
by: Eun Ju Yang, et al.
Published: (2021-06-01) -
Outcomes in pediatric studies of medium-chain acyl-coA dehydrogenase (MCAD) deficiency and phenylketonuria (PKU): a review
by: Michael Pugliese, et al.
Published: (2020-01-01) -
ECAD to MCAD Interoperability for Automated Enclosure Design
by: Wilcox, Adam C.
Published: (2008) -
Measuring Core Outcomes from Metabolic Chart-Abstracted Data for Medium-Chain Acyl-CoA Dehydrogenase (MCAD) Deficiency
by: Iverson, Ryan
Published: (2020) -
Establishing core outcome sets for phenylketonuria (PKU) and medium-chain Acyl-CoA dehydrogenase (MCAD) deficiency in children: study protocol for systematic reviews and Delphi surveys
by: Beth K. Potter, et al.
Published: (2017-12-01)